Fuzhou General Hospital
Fuzhou General Hospital
Explore linked clinical trials.9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2026-04-13 | NCT06434649 | |
| Therapy for Advanced NSCLC With EGFR 19delins Mutation | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Early phase 1 | 2026-03-09 | NCT07458919 | |
| Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2025-07-30 | NCT07093762 | |
| SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules | neoplasm | Not yet recruiting | Not stated | 2025-03-31 | NCT06775587 | |
| SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer | Lung Cancer Patients | Not yet recruiting | Not stated | 2025-03-31 | NCT06775015 | |
| SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Not yet recruiting | Not stated | 2025-03-31 | NCT06775002 | |
| SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer | neoplasm | Not yet recruiting | Not stated | 2025-03-31 | NCT06772376 | |
| SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2025-03-31 | NCT06772363 | |
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma | Immunotherapy Esophagus Cancer | Recruiting | Phase 2 | 2024-02-07 | NCT05515315 |